The US Department of Health and Human Services (HHS) has warned that more than 32,000 of its staff could be furloughed if ...

US drugmaker AbbVie has announced plans to launch Elahere (mirvetuximab soravtansine-gynx) in the UK at a list price equal to ...

US biotech Star Therapeutics, which is developing best-in-class antibodies for bleeding disorders and other diseases, today ...

Privately-held French biotech focused on providing immuno-therapeutics Biomunex Pharmaceuticals today announced a capital ...

San Diego, USA-based biotech AnaptysBio saw its shares climb by 10.4% to $25.70 in pre-market trading, following its ...

Shares in Enanta Pharmaceuticals, a US biotech creating small molecule drugs for viral infections and immunological diseases, ...

US obesity firm Metsera has presented new data that demonstrates why pharma giant Pfizer is paying up to $7.3 billion to buy ...

Shares of US clinical-stage biotech Dogwood Therapeutics soared a massive 43% to $7.91 yesterday, on the news it has secured ...

US eye disease specialist Kala Bio saw its shares close down almost 90% at $2.04 yesterday, after it revealed disappointing ...

President Donald Trump has called on US industries to put America first, and the biopharmaceutical sector is answering that ...

China-Belgium biotech Full-Life Technologies has raised $77 million through a mix of $50 million series C equity and $27 million debt financing. The cash will accelerate its radiopharmaceutical ...

US health technology body ICER will review the comparative clinical effectiveness and value of four COVID-19 vaccines: Pfizer ...